UnitedHealth Group Incorporated (UNH) is showing signs of a strong recovery, with improved profitability despite serving fewer members. The company's third-quarter results highlight Optum's operational turnaround and UnitedHealthcare's pricing discipline, which are restoring margins even as revenues and enrollment face pressure. Optum Health, for instance, saw its operating profit rise to $735 million from just $41 million a year earlier, though its margin remains below management's target of 6-8% by 2028.
Optum Health's revenues declined 10% to $22.9 billion as the company exited markets where its value-based care presence lacked sufficient scale. However, growth opportunities in home health, surgery centers, and complex-care management could drive future revenue growth. Optum Rx and Optum Insight also contributed to earnings, with operating margins improving to 4.3% and 23.4%, respectively.
UnitedHealthcare's operating earnings rose to $2.83 billion from $1.81 billion, despite a slight revenue decline. The company's medical care ratio dropped to 88.4% from 89.9%, indicating better pricing and claims management. However, the election results could introduce regulatory uncertainty, as Democrats may push for policy changes affecting the healthcare industry.
Looking ahead, UNH's stock has gained 19.4% year-to-date, outperforming the S&P 500 but trailing the industry. The company's adjusted EPS guidance for 2026 was raised to at least $20.50, with estimates projecting 26.1% year-over-year growth. Despite these positive signs, risks such as elevated medical costs and reimbursement pressures remain challenges for sustained profitability.